Sanofi Aventis unit Genzyme has unveiled a €150m expansion of its biotechnology site in Waterford, Ireland.
Around €500m has been invested in the site in past ten years. The latest upgrade has seen manufacturing capacity increased, and improvement made to laboratory facilities and administration offices.
The inauguration follows a series of high profile investments in the Irish pharmaceutical market, with both Merck and Pfizer recently unveiling new facilities in the nation.
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Pharmaceutical Technology Excellence Awards - Have you nominated?
Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!
Nominate Now
